Venus Remedies

Venus Remedies Ltd Balance Sheet

NSEBSE

₹459.35

(-0.96%)

Sep 5, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Venus Remedies Ltd

FINANCIALS

Profit & Loss Balance Sheet Cash Flow Ratios Results

ConsolidatedStandalone

GraphTable

Y/e 31 Mar( In .Cr)	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Equity Capital	13.37	13.37	13.37	13.37
Preference Capital	0	0	0	0
Reserves	576.13	495.22	464.68	436.05
Net Worth	589.5	508.59	478.05	449.42
Minority Interest
Debt	0	38.68	38.68	38.68
Deferred Tax Liability Net	28.41	28.78	43.43	32.81
Total Liabilities	617.91	576.05	560.16	520.91
Fixed Assets	240.53	223.85	225.77	249.9
Intangible Assets
Investments	84.24	19.24	20.27	0.14
Deferred Tax Asset Net	12.83	17.86	32.78	33.49
Networking Capital	202.31	247.46	228.01	187.4
Inventories	100.49	117.81	113.6	125.63
Inventory Days				79.72
Sundry Debtors	99.26	89.54	84.92	30.41
Debtor Days				19.29
Other Current Assets	110.69	123.18	111.02	121.92
Sundry Creditors	-68.6	-51.74	-48.95	-50.2
Creditor Days				31.85
Other Current Liabilities	-39.53	-31.33	-32.58	-40.36
Cash	77.99	67.64	53.3	49.97
Total Assets	617.9	576.05	560.13	520.9

Venus Remedies : related Articles

Venus Remedies Secures Ukrainian GMP Certification for Baddi Facility

The Unit-II Baddi plant, which got the renewed certification, has state-of-art infrastructure and state-of-the-art manufacturing technology to cater to complex therapeutic segments in an efficient manner.

22 May 2025|12:41 PM

Venus Remedies Secures Key Approvals, Strengthens Global Market Reach

The company is now set to further expand into Eastern Europe as this recognition ensures patients and healthcare providers have access to reliable and effective antibiotics.

31 Dec 2024|09:16 PM